Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) FCF Margin (2023 - 2025)

Upstream Bio has reported FCF Margin over the past 3 years, most recently at 4601.95% for Q4 2025.

  • Quarterly results put FCF Margin at 4601.95% for Q4 2025, down 137242.0% from a year ago — trailing twelve months through Dec 2025 was 4673.9% (down 216938.0% YoY), and the annual figure for FY2025 was 4675.54%, down 215727.0%.
  • FCF Margin for Q4 2025 was 4601.95% at Upstream Bio, down from 3257.39% in the prior quarter.
  • Over the last five years, FCF Margin for UPB hit a ceiling of 1575.69% in Q2 2024 and a floor of 7272.97% in Q1 2025.
  • Median FCF Margin over the past 3 years was 3257.39% (2025), compared with a mean of 3638.83%.
  • Biggest five-year swings in FCF Margin: soared 35047bps in 2024 and later plummeted -452891bps in 2025.
  • Upstream Bio's FCF Margin stood at 3580.0% in 2023, then increased by 10bps to 3229.53% in 2024, then tumbled by -42bps to 4601.95% in 2025.
  • The last three reported values for FCF Margin were 4601.95% (Q4 2025), 3257.39% (Q3 2025), and 4187.73% (Q2 2025) per Business Quant data.